Trial Profile
A study evaluating acceptance and safety of axillary testosterone gel (Axiron) in patients with symptomatic hypogonadism
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2018
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Adverse reactions; Therapeutic Use
- 14 Feb 2018 New trial record